Antitumor Efficacy and Reduced Toxicity Using an Anti-CD137 Probody Therapeutic

By
Justin.choi
-
0
20
A protease-activated prodrug form of the anti-mouse CD137 agonist antibody 1D8 was constructed and found to be selectively activated in the tumor microenvironment.
[Proceedings of the National Academy of Sciences of the United States of America]
Abstract